Geetika Sethi, Ph.D. - Publications

2013 Biochemistry and Molecular Biology Drexel University College of Medicine, Philadelphia, PA, United States 
Molecular Biology, Biostatistics Biology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Pathak HB, Zhou Y, Sethi G, Hirst J, Schilder RJ, Golemis EA, Godwin AK. A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer. Plos One. 10: e0144126. PMID 26637171 DOI: 10.1371/Journal.Pone.0144126  0.32
2015 Sethi G, Chopra G, Samudrala R. Multiscale modelling of relationships between protein classes and drug behavior across all diseases using the CANDO platform Mini-Reviews in Medicinal Chemistry. 15: 705-717. DOI: 10.4172/0974-276X.C1.079  0.32
2014 Sethi G, Kwon Y, Burkhalter RJ, Pathak HB, Madan R, McHugh S, Atay S, Murthy S, Tawfik OW, Godwin AK. PTN signaling: Components and mechanistic insights in human ovarian cancer. Molecular Carcinogenesis. PMID 25418856 DOI: 10.1002/Mc.22249  0.32
2014 Sharma P, Stecklein SR, Kimler BF, Sethi G, Petroff BK, Phillips TA, Tawfik OW, Godwin AK, Jensen RA. The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer. Journal of Cancer Therapeutics & Research. 3: 1-11. PMID 25177489 DOI: 10.7243/2049-7962-3-2  0.32
2014 Minie M, Chopra G, Sethi G, Horst J, White G, Roy A, Hatti K, Samudrala R. CANDO and the infinite drug discovery frontier. Drug Discovery Today. 19: 1353-63. PMID 24980786 DOI: 10.1016/J.Drudis.2014.06.018  0.32
2014 Atay S, Banskota S, Crow J, Sethi G, Rink L, Godwin AK. Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proceedings of the National Academy of Sciences of the United States of America. 111: 711-6. PMID 24379393 DOI: 10.1073/Pnas.1310501111  0.32
2013 Pessetto ZY, Weir SJ, Sethi G, Broward MA, Godwin AK. Drug repurposing for gastrointestinal stromal tumor. Molecular Cancer Therapeutics. 12: 1299-309. PMID 23657945 DOI: 10.1158/1535-7163.Mct-12-0968  0.32
2013 Sethi G, Pathak H, Zhang H, Zhou Y, Einarson MB, Vathipadiekal V, Gunewardena S, Birrer MJ, Godwin AK. Abstract A06: Integration of synthetic lethality and genomic data to identify significant molecular vulnerabilities in ovarian cancer Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Pms-A06  0.32
2012 Sethi G, Pathak HB, Zhang H, Zhou Y, Einarson MB, Vathipadiekal V, Gunewardena S, Birrer MJ, Godwin AK. An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer. Plos One. 7: e47086. PMID 23056589 DOI: 10.1371/Journal.Pone.0047086  0.32
2012 Somasundaram RT, Ramalingam S, Subramaniam D, Sethi G, Weir J, Nirmalanandhan VS, Godwin AK, Shrikant A, Sittampalam GS. Abstract 433: Expression of stem cell and EMT markers on circulating tumor cells Cancer Research. 72: 433-433. DOI: 10.1158/1538-7445.Am2012-433  0.32
2011 Sethi G, Pathak HB, Zhang H, Zhou Y, Einarson M, Godwin AK. Abstract 4969: RNA interference screens to identify genes essential for ovarian tumor growth and maintenance Cellular and Molecular Biology. 71: 4969-4969. DOI: 10.1158/1538-7445.Am2011-4969  0.32
Show low-probability matches.